Hologic’s 3D Mammography to be the “New Standard of Care”
Hologic’s 3D Mammography Technology to be the “New Standard of Care,”According to Healthcare Research Firm KLAS
98% of Providers Interviewed Say They Would Buy 3D Mammography Again
BEDFORD, Mass., March 19, 2013 /PRNewswire/ — “… Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the results of an independent survey by KLAS Research of Hologic 3D mammography sites in the U.S. The in-depth survey, which was not commissioned by Hologic, included fifty respondents whose facilities had used Hologic’s 3D mammography (breast tomosynthesis) technology for at least one year. The researcher reported that “providers are seeing cancers that they would not previously have seen with traditional digital mammography…”
“… In conventional 2D mammography, the presence of overlapping breast tissue can make it more difficult to detect cancer and to evaluate areas of suspicion. Hologic’s 3D mammography technology is designed to help overcome these limitations and allow doctors to see breast tissue more clearly, free from the interference of overlapping structures. Clinical data shows that the addition of 3D mammography to a 2D breast cancer screening exam significantly increases invasive cancer detection while greatly reducing unnecessary callbacks.
“Hologic is pleased that KLAS has validated the reasons why so many providers are adopting 3D mammography for their patients,” said Peter Soltani, Hologic’s Senior Vice President and General Manager of Women’s Health .”
“… The recently-published Oslo Tomosynthesis Screening Trial showed that screening with Hologic’s 3D mammography finds 40 percent more invasive cancers than traditional mammography alone…”